DrugBiological
Filgrastim clinical trials
Also written Neupogen, r-metHuG-CSF, rG-CSF and Tevagrastim.
- studies test it
- 430
- open now
- 38
- in phase 3
- 72
- first study started
- 1992
Keep track of what changes. Save the Filgrastim studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
423 studies that test it; most in 2016 (29)
| Year | Studies |
|---|---|
| 1992 | 1 |
| 1993 | 1 |
| 1994 | 4 |
| 1995 | 6 |
| 1996 | 13 |
| 1997 | 10 |
| 1998 | 11 |
| 1999 | 23 |
| 2000 | 22 |
| 2001 | 25 |
| 2002 | 15 |
| 2003 | 14 |
| 2004 | 22 |
| 2005 | 17 |
| 2006 | 10 |
| 2007 | 14 |
| 2008 | 6 |
| 2009 | 10 |
| 2010 | 20 |
| 2011 | 15 |
| 2012 | 14 |
| 2013 | 16 |
| 2014 | 19 |
| 2015 | 13 |
| 2016 | 29 |
| 2017 | 16 |
| 2018 | 9 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 7 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 12 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 8
- Phase 1
- 107
- Phase 2
- 241
- Phase 3
- 72
- Phase 4
- 26
- No phase
- 26
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 51 · Other 379
Children's Oncology Group (32) · M.D. Anderson Cancer Center (23) · National Cancer Institute (NCI) (18) · St. Jude Children's Research Hospital (15) · Washington University School of Medicine (13) · Alliance for Clinical Trials in Oncology (12) · Masonic Cancer Center, University of Minnesota (11) · University of Washington (10)
Often tested with
Tested in the same studies.
Granulocyte Colony-Stimulating Factor (140) · Cyclophosphamide (110) · Etoposide (60) · Fludarabine (55) · Cytarabine (48) · Vincristine (42) · Plerixafor (37) · Doxorubicin (36)
Studies
Open first, then newest update. How each study uses Filgrastim is read from its arms, and is right about nine times in ten.
Testing it · 430
- Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIMEnrolling by invitationPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT07775313Written as Filgrastim
- A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid LeukemiaRecruitingPhase 1National Cancer Institute (NCI)NCT07012044Written as Filgrastim
- G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell TransplantationRecruitingPhase 2Fudan UniversityNCT07362810Written as G-CSF+IL-11
- A Study to Compare the Pharmacokinetics, Pharmacodynamics, Immunogenicity, Safety and Tolerability of Filgrastim Biosimilar and Neupogen Reference Product in Healthy VolunteersNot yet recruitingPhase 1BioGeneric PharmaNCT07877467Written as Neupogen (filgrastim)
- Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine ModelsRecruitingPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT02015013Written as Filgrastim
- Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene TherapyEnrolling by invitationPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT06851767Written as Filgrastim
- Study of G-CSF for DOR in Patients Undergoing IVFRecruitingPhase 4Center for Human ReproductionNCT07871825Written as Neupogen 300 μg subcutaneous injection
- Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeRecruitingPhase 2M.D. Anderson Cancer CenterNCT00801489Written as Filgrastim-sndz
- Stem Cell Mobilization and Apheresis for Life-threatening Blood DisordersRecruitingPhase 1St. Jude Children's Research HospitalNCT07585136Written as Filgrastim
- Improving White Blood Cell Collection From Healthy DonorsRecruitingPhase 4National Institutes of Health Clinical Center (CC)NCT01553214Written as Filgrastim
- A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)RecruitingPhase 1/2GlaxoSmithKlineNCT07602777Written as G-CSF
- CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic LeukemiaRecruitingPhase 1Fred Hutchinson Cancer CenterNCT04375631Written as Filgrastim
- Haploidentical HCT for Severe Aplastic AnemiaRecruitingPhase 2St. Jude Children's Research HospitalNCT04558736Written as G-CSF
- Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed MedulloblastomaRecruitingPhase 2St. Jude Children's Research HospitalNCT05535166Written as Filgrastim
- Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma PatientsRecruitingPhase 3Guangzhou Gloria Biosciences Co., Ltd.NCT06514508Written as Motixafortide+G-CSF
- Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell TumoursRecruitingPhase 3University of SydneyNCT02582697Written as Filgrastim
- CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and LymphomaRecruitingPhase 1St. Jude Children's Research HospitalNCT07257419Written as Filgrastim
- Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous DiseaseRecruitingPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT06325709Written as Filgrastim
- Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell DiseaseRecruitingPhase 2St. Jude Children's Research HospitalNCT07616154Written as Filgrastim
- Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic DonorsRecruitingPhase 3First Affiliated Hospital of Zhejiang UniversityNCT07692841Written as Single-dose Granulocyte colony-stimulating factor (G-CSF)
See all 430 studies that test Filgrastim →
Given in every arm · 401 — Filgrastim is usual care beside what is tested
- The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell TransplantationRecruitingPhase 1/2National Cancer Institute (NCI)NCT05436418Written as Filgrastim
- Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic MalignanciesRecruitingPhase 1/2National Cancer Institute (NCI)NCT04959175Written as Filgrastim
- Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal TumorsNot yet recruitingPhase 2Joal BeaneNCT07647068Written as Filgrastim
- Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AMLNot yet recruitingPhase 1/2M.D. Anderson Cancer CenterNCT07604233Written as Filgrastim
- Paclitaxel-Bleomycin/Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin in Poor-prognosis Non-seminomatous Germ Cell Tumors (NSGCT) and Unfavorable Tumor Marker Decline: Randomized Phase II TrialRecruitingPhase 2Blokhin's Russian Cancer Research CenterNCT07847190Written as G-CSF (Filgrastim)
- A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCTRecruitingPhase 2Children's Oncology GroupNCT04684368Written as Filgrastim
- Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid LeukemiaRecruitingPhase 1/2M.D. Anderson Cancer CenterNCT03214562Written as Filgrastim
- hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)RecruitingPhase 2Leland MethenyNCT05052957Written as Filgrastim
- Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/LymphomaRecruitingPhase 2University of WashingtonNCT07224100Written as Filgrastim
- Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple MyelomaNot yet recruitingPhase 1University of California, DavisNCT07759102Written as Filgrastim
- Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple MyelomaRecruitingPhase 2M.D. Anderson Cancer CenterNCT06207799Written as G-CSF
- Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced MalignanciesRecruitingPhase 1/2University of California, IrvineNCT07064018Written as Filgrastim
- Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell TransplantRecruitingPhase 1/2M.D. Anderson Cancer CenterNCT04022239Written as Filgrastim-sndz
- Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationRecruitingEarly Phase 1C17 CouncilNCT06942039Written as Filgrastim
- Brentuximab Vedotin in Early Stage Hodgkin LymphomaRecruitingPhase 3University College, LondonNCT04685616Written as Haematopoietic growth factor
- Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk DiseaseRecruitingPhase 2St. Jude Children's Research HospitalNCT06023641Written as Filgrastim, peg-filgrastim
- Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal AdenocarcinomaNot yet recruitingPhase 2Abramson Cancer Center at Penn MedicineNCT07059611Written as Filgrastim
- Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell LymphomasRecruitingPhase 1City of Hope Medical CenterNCT07278856Written as Filgrastim
- MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.RecruitingPhase 2Masonic Cancer Center, University of MinnesotaNCT06412497Written as Post-Transplant G-CSF
- TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic MalignanciesRecruitingPhase 1St. Jude Children's Research HospitalNCT07052370Written as Filgrastim
Showing 20 of 401.
As the comparator · 38 — what is tested is compared with Filgrastim
- G-CSF In Neonatal Sepsis With NeutropeniaNot yet recruitingNot applicableUniversity of Health Sciences LahoreNCT07888829Written as Granulocyte-colony stimulating factor (G-CSF)
- A-TANGO Phase 2 StudyRecruitingPhase 2Yaqrit LtdNCT06890039Written as G-CSF (Filgrastim)
- Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid TumorsRecruitingPhase 2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT06926751Written as filgrastim
- The Value of Peripheral Blood CD34+ Cell Dynamics Monitoring in Autologous Hematopoietic Stem Cell Transplant MobilizationNot yet recruitingEarly Phase 1Zhongnan HospitalNCT05970185Written as G-CSF
- Lapelga vs GastrofilNot yet recruitingPhase 3London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sNCT06116734Written as Grastofil®
- A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) MutationCompletedPhase 3Astellas Pharma IncNCT03182244Written as G-CSF
- Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant FailureActive, not recruitingPhase 2National Heart, Lung, and Blood Institute (NHLBI)NCT02105766Written as Filgrastim
- Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ FunctionActive, not recruitingPhase 1/2National Heart, Lung, and Blood Institute (NHLBI)NCT06145282Written as Filgrastim
- Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell DiseaseActive, not recruitingPhase 1/2National Heart, Lung, and Blood Institute (NHLBI)NCT03077542Written as Filgrastim
- Study to Compare the Efficacy and Safety of F-627 and GRAN®CompletedPhase 3EVIVE BiotechnologyNCT04174599Written as GRAN®
- Specialized Blood Cell Transplants for Cancers of the Blood and Bone MarrowCompletedPhase 2National Heart, Lung, and Blood Institute (NHLBI)NCT00003838Written as G-CSF
- A Study of KRN125 in Patients With Multiple Myeloma and Malignant LymphomaCompletedPhase 2Kyowa Kirin Co., Ltd.NCT05007652Written as KRN8601(filgrastim), PLR001(plerixafor)
- Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AMLTerminatedPhase 3Cornerstone PharmaceuticalsNCT03504410Written as Fludarabine, Cytarabine, Filgrastim
- Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD ProphylaxisCompletedPhase 2Virginia Commonwealth UniversityNCT02593123Written as Filgrastim
- Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed NeulastaCompletedPhase 1Mylan Inc.NCT02479646Written as EU-Neulasta
- Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial CancerCompletedPhase 3GOG FoundationNCT00063999Written as Filgrastim
- A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer PatientsCompletedPhase 3Dong-A ST Co., Ltd.NCT03343145Written as Neupogen 5µg/kg/day
- GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCTStatus unknownPhase 2/3Post Graduate Institute of Medical Education and Research, ChandigarhNCT03911037Written as G-CSF
- Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate CancerTerminatedPhase 1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT02478125Written as G-CSF
- G-CSF in Decompensated Cirrhosis: an Open Label TrialStatus unknownPhase 2/3Post Graduate Institute of Medical Education and Research, ChandigarhNCT03415698Written as G-CSF
Showing 20 of 38.
Codes
What other systems call Filgrastim · ClinicalTrials.gg INT006616
- MeSH (NLM) D000069585FilgrastimConfirmed NLM, Wikidata
- UNII (FDA) PVI5M0M1GWFILGRASTIMConfirmed FDA, NLM, Wikidata
- RxNorm 68442Confirmed FDA, Wikidata
- Wikidata Q3151081filgrastimConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1474FilgrastimOne source FDA
- DrugBank DB00099One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069585 | Filgrastim | Confirmed NLM, Wikidata |
| UNII (FDA) | PVI5M0M1GW | FILGRASTIM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 68442 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3151081 | filgrastim | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1474 | Filgrastim | One source FDA |
| DrugBank | DB00099 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.